For decades, Alzheimer’s disease (AD) research has been dominated by the amyloid cascade hypothesis, which positions amyloid-beta (Aβ) accumulation as the primary driver of the disease. However, the consistent failure of Aβ-targeted therapies to demonstrate efficacy, coupled with significant safety concerns, has underscored the critical need to rethink our approach to AD treatment. In our […]

Read More »

We are delighted to announce that the Zanos Laboratory has secured €600,000 in research funding by the Research and Innovation Foundation, to support several innovative research programs in neuroscience and mental health. This funding will enable our laboratory to pursue multiple distinct lines of investigation that address important questions in mental health research. In collaboration […]

Read More »

We are excited to share that Dr. Zanos, Director of the Translational Neuropharmacology Lab, delivered an engaging talk at the 14th Annual Scientific Conference of the Center for Applied Neuroscience (CAN), held at the University of Cyprus. His presentation, titled “From Whiskers to Wisdom: How Rodent Models can Reveal Neural Mechanisms Underlying Decision-Making and Cognitive […]

Read More »

We are thrilled to announce that Dr. Zanos, the Director of the Translational Neuropharmacology Lab, has been invited to serve on the Education & Training Committee of the American College of Neuropsychopharmacology (ACNP) for the term 2025–2027. This prestigious invitation comes directly from ACNP President-Elect, Prof. William A. Carlezon, recognizing Dr. Zanos’s significant contributions to […]

Read More »

Dr. Panos Zanos, the Director of the Translational Neuropharmacology Lab, proudly announces the establishment of the Cyprus Neuroscience Society (C.N.S.)—a pioneering achievement for the neuroscience-related scientific community in Cyprus. Together with 20 founding members representing various neuroscience disciplines, the founding Director of the Society, Dr. Zanos collaborates with leading neuroscientists across the country to cultivate a deeper […]

Read More »

We are thrilled to announce that Dr. Panos Zanos, the Principal Investigator of the Translational Neuropharmacology Lab, has been appointed as a member of the Cyprus National Bioethics Committee (CNBC) following a rigorous application and interview process. The CNBC plays a pivotal role in advising and guiding ethical practices in research, healthcare, and policy-making in […]

Read More »

We are excited to share that Stylianos Valiantis, a talented Ph.D. student in the Translational Neuropharmacology Lab, has been awarded a fellowship to support their doctoral training! This highly competitive award, granted based on academic merit and research potential, highlights our Ph.D. students’ potential to advancing neuroscience research. Their work focuses on uncovering novel mechanisms […]

Read More »

We are excited to announce that Dr. Andrea Georgiou, our esteemed Marie-Curie Fellow at the Zanos Lab, has secured her first grant as Principal Investigator! The Research and Innovation Foundation in Cyprus has awarded Dr. Georgiou a prestigious €150,000 grant to advance her innovative research program. Dr. Georgiou’s funded project focuses on unraveling the molecular […]

Read More »

We are thrilled to announce that the Translational Neuropharmacology Lab (Zanos Lab) has been awarded €100,000 in state funds to support our cutting-edge research. These funds will be used to upgrade our laboratory equipment and ensure a steady supply of essential consumables, enabling us to advance our mission of understanding and developing novel therapies for […]

Read More »

We are excited to announce that Dr. Onisiforou from our lab is currently participating in IDWeek 2024, taking place in Los Angeles, USA. IDWeek is a premier international conference bringing together researchers and clinicians to discuss the latest advancements in infectious diseases. At the conference, Dr. Onisiforou is presenting her novel research on the molecular […]

Read More »